0001209191-19-003552.txt : 20190114 0001209191-19-003552.hdr.sgml : 20190114 20190114163535 ACCESSION NUMBER: 0001209191-19-003552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190111 FILED AS OF DATE: 20190114 DATE AS OF CHANGE: 20190114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shah Pritesh CENTRAL INDEX KEY: 0001744884 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37565 FILM NUMBER: 19525380 MAIL ADDRESS: STREET 1: C/O NOVOCURE INC. STREET 2: 20 VALLEY STREAM PARKWAY, SUITE 300 CITY: MALVERN STATE: PA ZIP: 19355 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NovoCure Ltd CENTRAL INDEX KEY: 0001645113 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF BUSINESS PHONE: 44 (0)15 3475 6700 MAIL ADDRESS: STREET 1: NO. 4 THE FORUM STREET 2: GRENVILLE STREET CITY: ST. HELIER STATE: Y9 ZIP: JE2 4UF FORMER COMPANY: FORMER CONFORMED NAME: Novocure Ltd DATE OF NAME CHANGE: 20150615 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-11 0 0001645113 NovoCure Ltd NVCR 0001744884 Shah Pritesh C/O NOVOCURE INC., 20 VALLEY STREAM PARKWAY, SUITE 300 MALVERN PA 19355 0 1 0 0 Chief Commercial Officer Ordinary Shares 2019-01-11 4 M 0 8751 14.37 A 25838 D Ordinary Shares 2019-01-11 4 S 0 8751 42.004 D 17087 D Ordinary Shares 2019-01-11 4 M 0 17500 11.46 A 34587 D Ordinary Shares 2019-01-11 4 S 0 17500 42.004 D 17087 D Options to Buy Ordinary Shares 14.37 2019-01-11 4 M 0 8751 0.00 D 2025-02-23 Ordinary Shares 8751 0 D Options to Buy Ordinary Shares 11.46 2019-01-11 4 M 0 17500 0.00 D 2026-02-24 Ordinary Shares 17500 7463 D Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah. On January 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 8,751 shares in multiple trades at prices ranging from $42.00 to $42.03. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. On January 11, 2019, pursuant to a Rule 10b5-1 trading plan adopted by Mr. Shah, Mr. Shah sold 17,500 shares in multiple trades at prices ranging from $42.00 to $42.03. The price reported above reflects the weighted average sale price. Mr. Shah hereby undertakes to provide to the Staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected. Options exercised were fully vested as of the date hereof. /s/ Kimberly Burke, Attorney in fact for Pritesh Shah 2019-01-14